Nifedipine, L-type Ca2+ channel blocker (ab120135)
Key features and details
- L-type Ca2+ channel blocker
- CAS Number: 21829-25-4
- Soluble in DMSO to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Nifedipine, L-type Ca2+ channel blocker -
Description
L-type Ca2+ channel blocker -
Biological description
L-type Ca2+ channel blocker. Potent, long-acting vasodilator. Also shown to inhibit vascular inflammation.
-
CAS Number
21829-25-4 -
Chemical structure
Properties
-
Chemical name
1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester -
Molecular weight
346.34 -
Molecular formula
C17H18N2O6 -
PubChem identifier
4485 -
Storage instructions
Store at +4°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in DMSO to 100 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
CC=1NC(C)=C(C(C=1C(=O)OC)c2ccccc2[N+]([O-])=O)C(=O)OC -
Source
Synthetic
-
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab120135 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| Functional Studies |
Use at an assay dependent concentration.
|
| Notes |
|---|
|
Functional Studies
Use at an assay dependent concentration. |
Images
-
Chemical Structure - Nifedipine, L-type Ca2+ channel blocker (ab120135)2D chemical structure image of ab120135, Nifedipine, L-type Ca2+ channel blocker
-
Functional Studies - Nifedipine, L-type Ca2+ channel blocker (ab120135)ab2770 staining aryl hydrocarbon receptor in MDA-MB-231 cells treated with nifedipine (ab120135), by ICC/IF. Increase in aryl hydrocarbon receptor expression correlates with increased concentration of nifedipine, as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120135 (nifedipine) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab2770 (1/100 dilution) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-mouse polyclonal antibody (ab96879) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (12)
ab120135 has been referenced in 12 publications.
- Wong E et al. Phototransduction in a marine sponge provides insights into the origin of animal vision. iScience 25:104436 (2022). PubMed: 35707725
- Wang T et al. Allopregnanolone Modulates GABAAR-Dependent CaMKIId3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage. Front Cell Neurosci 13:569 (2019). PubMed: 31998078
- Zhang F & Tzanakakis ES Optogenetic regulation of insulin secretion in pancreatic ß-cells. Sci Rep 7:9357 (2017). PubMed: 28839233
- Favuzzi E et al. Activity-Dependent Gating of Parvalbumin Interneuron Function by the Perineuronal Net Protein Brevican. Neuron 95:639-655.e10 (2017). PubMed: 28712654
- Toft-Bertelsen TL et al. Regulation of Ca2+ channels by SNAP-25 via recruitment of syntaxin-1 from plasma membrane clusters. Mol Biol Cell 27:3329-3341 (2016). PubMed: 27605709